Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Get up-to-the-minute Globe Business Updates   |  More Business News
	ADVERTISEMENT Friday, February 4, 2011 BG Medicine stock starts trading $7 per share Shares of life sciences company BG Medicine Inc. debuted at $7 Friday and are rising sharply in midday trading. Bus line offers free rides to NYC Boston and New York have long had a love-hate relationship, but a bus company new to the local market wants to show love to both cities by offering free rides as part of a Valentine's Day promotion. Sun Life inks golfing pitchman Sun Life Financial said it has signed up golfer Hunter Mahan to promote its products in deal that the company said is its first sponsorship in the world of professional golf. Hologic receives approval for premature birth drug BEDFORD -- A drug from Hologic Inc. designed to prevent premature birth was approved by federal regulators, the company said Friday, but ongoing studies will be required. Workshops school job seekers in social networking Many One-Stop Career Centers in Massachusetts are now offering social networking workshops designed to train job seekers in Internet technologies that many employers are now using to not only hire, but also run their businesses said. Ameresco helps Children’s Hospital get greener Ameresco Inc., a Framingham company that helps customers to become more energy efficient, said that it has finalized the fifth phase of its energy efficiency agreement with Children's Hospital Boston. TripAdvisor buys EveryTrail TripAdvisor, the Newton-based travel review website, said it has bought a California company called Everytrail to help provide more information to travelers with smartphones. Sam Adams: Have a ‘hoppy’ Valentine’s Day Samuel Adams has devised a beer-themed gift for Valentine's Day. Vertex books bigger 4Q loss on research costs CAMBRIDGE -- Vertex Pharmaceuticals Inc. reported a larger fourth-quarter loss on Thursday as it spent more money to develop its hepatitis C drug candidate telaprevir, along with a potential cystic fibrosis treatment and other drugs. Thursday, February 3, 2011 NY Times Co. reports profit drop The New York Times Co. reported an operating profit of $111.6 million in the fourth quarter, an 18 percent decline.